{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:53:50Z","timestamp":1791003230873,"version":"4.1.0"},"reference-count":32,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2026,9,30]]},"DOI":"10.1536\/ihj.26-328","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:10:53Z","timestamp":1789078253000},"page":"423-428","source":"Crossref","is-referenced-by-count":0,"title":["Goreisan for Heart Failure"],"prefix":"10.1536","volume":"67","author":[{"given":"Teruhiko","family":"Imamura","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kitai T, Kohsaka S, Kato T, <i>et al<\/i>; Japanese Circulation S, the Japanese Heart Failure Society Joint Working G. JCS\/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure. Circ J 2025; 89: 1278-444.","DOI":"10.1253\/circj.CJ-25-0480"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McDonagh TA, Metra M, Adamo M, <i>et al<\/i>; Group ESCSD. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023; 44: 3627-39.","DOI":"10.15829\/1560-4071-2023-5168"},{"key":"3","first-page":"e895","volume":"145","year":"2022","unstructured":"3. Heidenreich PA, Bozkurt B, Aguilar D, <i>et al<\/i>; Members AAJC. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e895-1032.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cox ZL, Damman K, Testani JM. Decongestion in heart failure: medical and device therapies. Nat Rev Cardiol 2025; 22: 961-77.","DOI":"10.1038\/s41569-025-01152-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mullens W, Damman K, Harjola VP, <i>et al<\/i>. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019; 21: 137-55.","DOI":"10.1002\/ejhf.1369"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 75: 1178-95.","DOI":"10.1016\/j.jacc.2019.12.059"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Isogai T, Michihata N, Okada A, <i>et al<\/i>. Use of Japanese Herbal Kampo Medicine in Patients With Acute Cardiovascular Disease - A 12-Year Nationwide Cohort Analysis. Circ J 2024; 88: 1322-31.","DOI":"10.1253\/circj.CJ-23-0770"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yaku H, Kaneda K, Kitamura J, Kato T, Kimura T. Kampo medicine for the holistic approach to older adults with heart failure. J Cardiol 2022; 80: 306-12.","DOI":"10.1016\/j.jjcc.2021.12.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J 2021; 42: 681-3.","DOI":"10.1093\/eurheartj\/ehaa1012"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet 2024; 403: 1083-92.","DOI":"10.1016\/S0140-6736(23)02756-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pham D, Grodin JL. Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure. Card Fail Rev 2017; 3: 108-12.","DOI":"10.15420\/cfr.2017:10:1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Imamura T, Narang N, Kinugawa K. Clinical implications of remote dielectric sensing system to estimate lung fluid levels. J Cardiol 2023; 81: 276-82.","DOI":"10.1016\/j.jjcc.2022.07.014"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Imamura T, Akazawa Y, Saito S, <i>et al<\/i>. Usefulness of Respiratory Stability Time-Guided Management to Prevent Readmission of Chronic Heart Failure Patients at Home: A Multicenter, Single-Arm, Open-Label Clinical Study (ITMETHOD-HF-III). J Clin Med 2025; 14: 4653.","DOI":"10.3390\/jcm14134653"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Rubio-Gracia J, Demissei BG, Ter Maaten JM, <i>et al<\/i>. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 2018; 258: 185-91.","DOI":"10.1016\/j.ijcard.2018.01.067"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Izumida T, Imamura T, Koi T, <i>et al<\/i>. Prognostic impact of residual pulmonary congestion assessed by remote dielectric sensing system in patients admitted for heart failure. ESC Heart Fail 2024; 11: 1443-51.","DOI":"10.1002\/ehf2.14690"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kobayashi M, Watanabe M, Coiro S, <i>et al<\/i>. Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure. Int J Cardiol 2019; 289: 91-8.","DOI":"10.1016\/j.ijcard.2019.01.091"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Coiro S, Rossignol P, Ambrosio G, <i>et al<\/i>. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 2015; 17: 1172-81.","DOI":"10.1002\/ejhf.344"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Akao K, Imamura T, Hida Y, Tanaka S, Ushijima R, Kinugawa K. Can clinicians quantify pulmonary congestion accurately using conventional modalities without remote dielectric sensing: ReDS quiz study. Heart Vessels 2026; 41: 319-31.","DOI":"10.1007\/s00380-025-02614-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Imamura T, Kinugawa K. Prognostic Impacts of Hyponatremia, Renal Dysfunction, and High-Dose Diuretics During a 10-Year Study Period in 4,087 Japanese Heart Failure Patients. Int Heart J 2016; 57: 657-8.","DOI":"10.1536\/ihj.16-227"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Talha KM, Pandey A, Fudim M, Butler J, Anker SD, Khan MS. Frailty and heart failure: State-of-the-art review. J Cachexia Sarcopenia Muscle 2023; 14: 1959-72.","DOI":"10.1002\/jcsm.13306"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Watanabe K, Matsuura K, Gao P, <i>et al<\/i>. Traditional Japanese Kampo Medicine: Clinical Research between Modernity and Traditional Medicine-The State of Research and Methodological Suggestions for the Future. Evid Based Complement Alternat Med 2011; 2011: 513842.","DOI":"10.1093\/ecam\/neq067"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Katayama K, Yoshino T, Munakata K, <i>et al<\/i>. Prescription of kampo drugs in the Japanese health care insurance program. Evid Based Complement Alternat Med 2013; 2013: 576973.","DOI":"10.1155\/2013\/576973"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Arai I. Clinical studies of traditional Japanese herbal medicines (Kampo): Need for evidence by the modern scientific methodology. Integr Med Res 2021; 10: 100722.","DOI":"10.1016\/j.imr.2021.100722"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yaku H, Kato T, Morimoto T, <i>et al<\/i>; Investigators G-Ht. Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial. Am Heart J 2023; 260: 18-25.","DOI":"10.1016\/j.ahj.2023.02.013"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kakeshita K, Imamura T, Onoda H, Kinugawa K. Impact of Goreisan upon aquaporin-2-incorporated aquaresis system in patients with congestive heart failure. CEN Case Rep 2023; 12: 73-7.","DOI":"10.1007\/s13730-022-00723-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Isayama YS, Matsushima S, Shinohara K, <i>et al<\/i>. Goreisan attenuates cardiac hypertrophy and diastolic dysfunction in heart failure with preserved ejection fraction induced by HFD\/L-NAME via regulation of ICAT-beta-catenin\/ERK axis. Hypertens Res 2025; 48: 2882-96.","DOI":"10.1038\/s41440-025-02348-z"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Funamoto M, Hirose S, Yamamoto M, <i>et al<\/i>. Goreisan suppresses cardiac remodeling and dysfunction in a new mouse model with diabetic cardiomyopathy. J Pharmacol Sci 2025; 157: 104-12.","DOI":"10.1016\/j.jphs.2025.01.003"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kakeshita K, Imamura T, Hida Y, Onoda H, Koike T, Kinugawa K. Trajectory of Urine Parameters by Adding Herbal Kampo Medicine Goreisan to Tolvaptan in Patients with Congestive Heart Failure. J Clin Med 2024; 13: 7523.","DOI":"10.3390\/jcm13247523"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hida Y, Imamura T, Kinugawa K. Mid-Term Impact of Kampo Goreisan in Patients with Congestive Heart Failure Receiving Tolvaptan-Incorporated Medical Therapy. J Clin Med 2026; 15: 3659.","DOI":"10.3390\/jcm15103659"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hida Y, Imamura T, Onoda H, Kakeshita K, Kinugawa K. Short-term impact of kampo goreisan in patients with congestive heart failure refractory to tolvaptan-incorporated medical therapy. Heart Vessels 2024; 39: 1029-35.","DOI":"10.1007\/s00380-024-02432-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sugihara R, Hashimura T, Sakata Y. Goreisan as a successful adjuvant therapy of heart failure with preserved ejection fraction and advanced chronic kidney disease: a case report. Oxf Med Case Reports 2023; 2023: omad116.","DOI":"10.1093\/omcr\/omad116"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Isogai T, Morita K, Okada A, <i>et al<\/i>. Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A nationwide propensity score-matched study. J Cardiol 2025; 85: 220-8.","DOI":"10.1016\/j.jjcc.2024.09.010"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/5\/67_26-328\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:25:13Z","timestamp":1791001513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/5\/67_26-328\/_article"}},"subtitle":["A Novel Congestion-Modulating Strategy beyond Conventional Diuretic Therapy"],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.26-328","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"26-328"}}